Reduced antibiotic prescribing for acute respiratory infections in adults and children

British Journal of General Practice

Volumn 59, Issue 567, 2009, Pages 735-741

  Meropol, Sharon B ^a   Chen, Zhen ^b   Metlay, Joshua P ^a,c,d  

^a Center for Education and Research on Therapeutics   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anti infective agents; Databases; Health services research; Prescriptions; Respiratory tract infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEPHALOSPORIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; PENICILLIN G; QUINOLONE; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; HEALTH PRACTITIONER; HUMAN; MEDICAL PRACTICE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRESCRIPTION; RESPIRATORY TRACT INFECTION; UNITED KINGDOM;

EID: 70350255701     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp09X472610     Document Type: Article

References (45)

1. Lonks JR, Garau J, Gomez L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Can Infect Dis 2002; 35(5): 556-564. (Pubitemid 34928784)
2. Interagency Task Force on Antimicrobial Resistance. A public health action plan to combat antimicrobial resistance. Part 1: domestic issues. Atlanta: Interagency Task Force on Antimicrobial Resistance, 1999. http://www.cdc.gov/drugresistance/actionplan/index.htm (accessed 23 Mar 2009).
3. Austrian R. Confronting drug-resistant pneumococci. Ann Intern Med 1994; 121(10): 807-809.
4. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3(2): 171-196.
5. Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30(3): 520-528. (Pubitemid 30205299)
6. Lipsitch M. The rise and fall of antimicrobial resistance. Trends Microbiol 2001; 9(9): 438-444.
7. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A 1999; 96(3): 1152-1156.
8. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002; 8(4): 347-354. (Pubitemid 34415194)
9. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278(11): 901-904. (Pubitemid 27492241)
10. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998; 279(11): 875-877. (Pubitemid 28185554)
11. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337(7): 441-446.
12. Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA 1996; 275(3): 175. (Pubitemid 26028544)
13. US Centers for Disease Control and Prevention, US Department of Human Services. Get SMART: know when antibiotics work. http://www.cdc.gov/getsmart/ (accessed 23 Mar 2009).
14. Standing Medical Advisory Committee Sub-Group on Anti-Microbial Resistance. The path of least resistance. http://www.advisorybodies.doh.gov.uk/ smac1.htm (accessed 23 Mar 2009).
15. Department of Health. Antibiotics: don't wear me out. London: Department of Health, 1999. www.dh.gov.uk//PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en? CONTENT-ID=4007460&chk=VHEgjn (accessed 23 Mar 2009).
16. Ashworth M, Golding S, Majeed A. Prescribing indicators and their use by primary care groups to influence prescribing. J Clin Pharm Ther 2002; 27(3): 197-204. (Pubitemid 34748144)
17. Grijalva, CG, Nuorty, JP, Griffin, MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009; 302(7): 758-766.
18. Halasa NB, Griffin MR, Zhu Y, Edwards KM. Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less man five years of age. Pediatr Infect Dis J 2002; 21(11): 1023-1028.
19. McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003; 9(4): 432-437.
20. Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States - 1995 to 2002. J Gen Intern Med 2005; 20(8): 697-702.
21. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003; 138(7): 525-533.
22. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287(23): 3096-3102.
23. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 2003; 289(6): 719-725. (Pubitemid 37430366)
24. Sharland M, Kendall H, Yeates D, et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis. BMJ 2005; 331(7512): 328-329. (Pubitemid 41113146)
25. Ashworth M, Latinovic R, Charlton J, et al. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. J Public Health (Oxf) 2004; 26(3): 268-274. (Pubitemid 39312930)
26. Frischer M, Heatlie H, Norwood J, et al. Trends in antibiotic prescribing and associated indications in primary care from 1993 to 1997. J Public Health Med 2001; 23(1): 69-73.
27. Fleming DM, Ross AM, Cross KW, Kendall H. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 2003; 53(495): 778-783. (Pubitemid 37254122)
28. Smith S, Smith GE, Heatlie H, et al. Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research database. Public Health 2006; 120(8): 752-759.
29. Epic Database Research Company Ltd. Cegedim Strategic Data. http://www.epic-uk.org/ (accessed 3 Sep 2009).
30. Gelfand J, Margolis, DJ, Dattani H. The UK General Practice Research Database. In: Strom BL (ed). Pharmacoepidemiology. Chichester: John Wiley & Sons, Ltd, 2005: 337-346.
31. Metlay JP KJ. Failure to validate pneumococcal pneumonia diagnoses in the General Practice Research Database [abstract]. Pharmacoepidemiol Drug Saf 2003; 12: S163.
32. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997; 87: 36-40.
33. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302(6779): 766-768.
34. Wood F, Simpson S, Butler CC. Socially responsible antibiotic choices in primary care: a qualitative study of GPs' decisions to prescribe broad-spectrum and fluroquinolone antibiotics. Fam Pract 2007; 24(5): 427-434. (Pubitemid 350142639)
35. Hing E, Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2004 summary. Adv Data 2006; 374: 1-33.
36. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154(9): 854-864. (Pubitemid 33000813)
37. Schneeweiss S, Wang PS, Avorn J, et al. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med 2004; 19(5 Part 1): 444-450. (Pubitemid 38638905)
38. Putnam KG, Buist DS, Fishman P, et al. Chronic disease score as a predictor of hospitalization. Epidemiology 2002; 13(3): 340-346. (Pubitemid 34415856)
39. Millar EV, O'Brien KL, Watt JP, et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis 2006; 43(1): 8-15.
40. O'Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007; 196(8): 1211-1220.
41. Lipsitch M, O'Neill K, Cordy D, et al. Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis 2007; 196(8): 1221-1227. (Pubitemid 47580277)
42. Kyaw M, Lynfield R, Schafner W, et al. Effect of introduction of the pneumocococcal conjuate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354(14): 1455-1463.
43. Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics 2003; 112(3 Part 1): 620-627.
44. Fleming DM, Cross KW, Barley MA. Recent changes in the prevalence of diseases presenting for health care. Br J Gen Pract 2005; 55(517): 589-595.
45. Hing E, Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2004 Summary. Advance Data from Vital and Health Statistics 2006; 374. http://www.cdc.gov/nchs/data/ad/ad374.pdf (accessed 23 Mar 2009).